Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.
Gregor DuweLukas MüllerChristian RuckesNikita Dhruva FischerLisa Johanna FreyJan Hendrik BörnerNiklas RölzMaximilian HaackPeter SparwasserTobias JorgChristopher C M NeumannIgor TsaurThomas HöfnerAxel HaferkampFelix HahnRene MagerMaximilian Peter BrandtPublished in: Biomedicines (2023)
We describe a new, innovative artificial intelligence-based approach of a radiological surrogate marker for IO response in aUC and aRCC which presents a promising new predictive imaging marker. The data presented implicate improved OS with lower follow-up SV in patients with aRCC.